Angiodynamics (ANGO) Net Cash Flow (2010 - 2026)
Angiodynamics' (ANGO) quarterly Net Cash Flow came in at $16.1 million in Q2 2026, up 54.29% YoY from $10.4 million in Q2 2025, and up 502.25% on a QoQ basis from -$4.0 million in Q1 2026.
Angiodynamics (ANGO) Net Cash Flow (2010 - 2026) Analysis & Trends
Angiodynamics (ANGO) has 17 years of Net Cash Flow data on file, last reported at $16.1 million in Q2 2026.
- Quarterly Net Cash Flow rose 54.29% year-over-year to $16.1 million in Q2 2026, while the trailing twelve-month figure through May 2026 was -$2.3 million (up 88.83% YoY) and the FY2026 annual result came in at -$2.3 million, up 88.83% from the prior year.
- Net Cash Flow grew to $16.1 million in Q2 2026, from -$4.0 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $17.6 million in Q1 2024 to a low of -$21.2 million in Q3 2024.
- A 5-year average of $1.1 million and a median of $1.6 million in 2023 frame the typical range for Net Cash Flow.
- The widest YoY moves for Net Cash Flow: up 10549.7% in 2024, down 263.41% in 2024.
- Tracing ANGO's Net Cash Flow over 5 years: stood at $5.1 million in 2022, then sank by 38.88% to $3.1 million in 2023, then plunged by 119.58% to -$611000.0 in 2024, then jumped by 582.49% to $2.9 million in 2025, then soared by 445.25% to $16.1 million in 2026.
- The last three Net Cash Flow figures came in at $16.1 million (Q2 2026), -$4.0 million (Q1 2026), and $2.9 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 746.50 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | -42.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | -222.00 Mn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | -192.18 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 95.00 Mn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | -84.00 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | -160.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 17.00 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 149.00 Mn |
| 10 | Angiodynamics | 658.19 Mn | 604.32 Mn | 46.77 Mn | 16.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 16.07 Mn |
| May 31, 2026 | 16.07 Mn |
| Feb 28, 2026 | -4.00 Mn |
| Feb 28, 2026 | -4.00 Mn |
| Nov 30, 2025 | 2.95 Mn |
| Nov 30, 2025 | 2.95 Mn |
| Aug 31, 2025 | -17.32 Mn |
| Aug 31, 2025 | -17.32 Mn |
| May 31, 2025 | 10.42 Mn |
| May 31, 2025 | 10.42 Mn |
| Feb 28, 2025 | -9.20 Mn |
| Feb 28, 2025 | -9.20 Mn |
| Nov 30, 2024 | -611,000.00 |
| Nov 30, 2024 | -611,000.00 |
| Aug 31, 2024 | -21.17 Mn |
| Aug 31, 2024 | -21.17 Mn |
| May 31, 2024 | -2.34 Mn |
| May 31, 2024 | -2.34 Mn |
| Feb 29, 2024 | 17.57 Mn |
| Feb 29, 2024 | 17.57 Mn |